Home Newsfeeds Deutsche Bank Initiates Coverage On Abcam with Hold Rating

Deutsche Bank Initiates Coverage On Abcam with Hold Rating

Deutsche Bank analyst Justin Bowers initiates coverage on Abcam (NASDAQ:ABCM) with a Hold rating.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Deutsche Bank analyst Justin Bowers initiates coverage on Abcam (NASDAQ:ABCM) with a Hold rating.

What’s Going On With Lucy Scientific Discovery Stock?

By Adam Eckert

July 13, 10:32 AM

Lucy Scientific Discovery Inc (NASDAQ: LSDI) shares are trading higher Thursday, adding to gains of nearly 5% over the last week.

LSDI

RBC Capital Downgrades Taylor Morrison Home to Sector Perform, Raises Price Target to $29

By Benzinga Newsdesk

July 28, 4:50 AM

RBC Capital analyst Mike Dahl downgrades Taylor Morrison Home (NYSE:TMHC) from Outperform to Sector Perform and raises the price target from $28 to $29.

TMHC

Nasdaq Drops Sharply, But Market Volatility Decreases

By Lisa Levin

November 17, 4:39 AM

US stocks closed lower on Wednesday, after Target Corporation (NYSE: TGT) posted downbeat quarterly results and issued weak holiday-sales outlook. The S&P 500 consumer discretionary sector, as a result, dipped 1.5% on Wednesday.

AMZN

Tempest Announces Publication Of Data From Phase 1 Trial Of TPST-1120 In Patients With Advanced Solid Tumors In Journal Of Cancer Research Communications

By Benzinga Newsdesk

April 4, 8:10 AM

TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data, Company preparing to

TPST

Deutsche Bank Initiates Coverage On Abcam with Hold Rating

Related Posts

What’s Going On With Lucy Scientific Discovery Stock?

RBC Capital Downgrades Taylor Morrison Home to Sector Perform, Raises Price Target to $29

Nasdaq Drops Sharply, But Market Volatility Decreases

Tempest Announces Publication Of Data From Phase 1 Trial Of TPST-1120 In Patients With Advanced Solid Tumors In Journal Of Cancer Research Communications